Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome
This study has been completed.
Study NCT00160355 Information provided by St. Jude Children's Research Hospital
First Received: September 8, 2005 Last Updated: February 12, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Wiskott-Aldrich Syndrome
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Blood Platelet Disorders
Disease
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Hematologic Diseases
Hemorrhagic Disorders
Immune System Diseases
Immunologic Deficiency Syndromes
Pathologic Processes
Purpura, Thrombocytopenic
Thrombocytopenia
Interventions listed in this trial
Miltenyi CliniMACS selection system
Fludarabine, Melphalan, Thiotepa
Additional drug interventions recognized in this trial
Fludarabine
Fludarabine monophosphate
Melphalan
Thiotepa
More general drug interventions related to this trial
Alkylating Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
St. Jude Children's Research Hospital
Back to top of Main Content
